Get the Stockscreener App
14.40
1.71%
-0.25
After Hours:
14.40
Mink Therapeutics Inc stock is traded at $14.40, with a volume of 37,008.
It is down -1.71% in the last 24 hours and up +1.41% over the past month.
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of allogeneic invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. The company is advancing a pipeline of both native and next generation engineered iNKT programs, with a platform designed to facilitate scalable and reproducible manufacturing for off-the-shelf delivery.
See More
Previous Close:
$14.65
Open:
$14.65
24h Volume:
37,008
Relative Volume:
0.04
Market Cap:
$65.13M
Revenue:
-
Net Income/Loss:
$-24.77M
P/E Ratio:
-19.73
EPS:
-0.73
Net Cash Flow:
$-17.36M
1W Performance:
-2.70%
1M Performance:
+1.41%
6M Performance:
+80.45%
1Y Performance:
+88.56%
1-Day Range:
$14.10
$14.98
1-Week Range:
$14.10
$16.20
52-Week Range:
$4.5601
$76.00
Mink Therapeutics Inc Stock (INKT) Company Profile
Name
Mink Therapeutics Inc
Sector
Industry
Phone
212-994-8250
Address
149 FIFTH AVENUE, NEW YORK
Compare INKT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INKT
Mink Therapeutics Inc
|
14.40 | 69.16M | 0 | -24.77M | -17.36M | -0.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Mink Therapeutics Inc Stock (INKT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-15-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
Mink Therapeutics Inc Stock (INKT) Latest News
How to read the order book for MiNK Therapeutics Inc.Global Markets & Expert Curated Trade Setup Alerts - Newser
Can volume confirm reversal in MiNK Therapeutics Inc.Portfolio Performance Report & AI Enhanced Trade Execution Alerts - Newser
Sector ETF performance correlation with MiNK Therapeutics Inc.2025 Price Momentum & Reliable Trade Execution Plans - Newser
Using economic indicators to assess MiNK Therapeutics Inc. potentialEarnings Beat & Reliable Price Breakout Signals - Newser
Understanding MiNK Therapeutics Inc.’s price movementWeekly Trade Recap & Verified Momentum Watchlists - Newser
Using Bollinger Bands to evaluate MiNK Therapeutics Inc.July 2025 Short Interest & Weekly Top Performers Watchlists - Newser
Will breakout in MiNK Therapeutics Inc. lead to full recoveryJuly 2025 Trends & Verified Momentum Watchlists - Newser
Can MiNK Therapeutics Inc. hit a new high this monthRate Hike & Fast Momentum Stock Entry Tips - Newser
Custom watchlist performance reports with MiNK Therapeutics Inc.Product Launch & High Return Trade Opportunity Guides - Newser
What MACD and RSI say about MiNK Therapeutics Inc.July 2025 Fed Impact & High Yield Equity Trading Tips - Newser
MiNK Therapeutics Inc. stock volume spike explainedJuly 2025 PostEarnings & Technical Confirmation Alerts - Newser
Chart Watch: Is MiNK Therapeutics Inc. a defensive stockEarnings Trend Report & Fast Exit Strategy with Risk Control - Lancaster City Council
MiNK Therapeutics Inc. Shows Risk Reward Favoring UpsideJuly 2025 Decliners & Low Drawdown Trading Strategies - beatles.ru
Combining price and volume data for MiNK Therapeutics Inc.Trade Volume Summary & Reliable Price Breakout Alerts - Newser
Can MiNK Therapeutics Inc. sustain earnings growthMarket Growth Report & AI Driven Stock Price Forecasts - خودرو بانک
How does MiNK Therapeutics Inc. compare to its peersQuarterly Risk Review & Short-Term Swing Trade Alerts - خودرو بانک
Mink Therapeutics’ Earnings Call: Clinical Progress Amid Financial Challenges - MSN
Is MiNK Therapeutics Inc. undervalued by DCF analysisEarnings Recap Report & Smart Swing Trading Techniques - خودرو بانک
Pattern recognition hints at MiNK Therapeutics Inc. upsideInsider Selling & Weekly Top Gainers Trade List - Newser
Is MiNK Therapeutics Inc. meeting your algorithmic filter criteria2025 Technical Overview & Smart Investment Allocation Insights - Newser
Will MiNK Therapeutics Inc. stock recover after recent drop2025 Technical Patterns & High Accuracy Swing Entry Alerts - Newser
What momentum shifts mean for MiNK Therapeutics Inc.Market Risk Report & AI Powered Market Trend Analysis - Newser
Applying Elliott Wave Theory to MiNK Therapeutics Inc.Entry Point & Safe Entry Momentum Tips - Newser
What’s the recovery path for long term holders of MiNK Therapeutics Inc.Quarterly Investment Review & Weekly Hot Stock Watchlists - Newser
Does MiNK Therapeutics Inc. qualify in momentum factor screening - Newser
What institutional flow reveals about MiNK Therapeutics Inc.July 2025 Catalysts & Free High Accuracy Swing Entry Alerts - Newser
What candlestick patterns are forming on MiNK Therapeutics Inc.Earnings Risk Summary & Daily Technical Forecast Reports - Newser
Comparing MiNK Therapeutics Inc. in custom built stock radarsMarket Growth Summary & Capital Protection Trading Alerts - Newser
What is MiNK Therapeutics Inc. s P E ratio telling usJuly 2025 PreEarnings & Free Long-Term Investment Growth Plans - خودرو بانک
Using Ichimoku Cloud for MiNK Therapeutics Inc. technicalsTrade Entry Summary & High Yield Equity Trading Tips - Newser
Will MiNK Therapeutics Inc. outperform the marketPortfolio Value Summary & Low Volatility Stock Suggestions - Newser
Market Review: Is MiNK Therapeutics Inc. stock forming a triangle patternJuly 2025 Setups & Low Risk Investment Opportunities - خودرو بانک
Is MiNK Therapeutics Inc. stock forming a triangle patternJuly 2025 Rallies & Real-Time Buy Zone Alerts - خودرو بانک
What are analysts’ price targets for MiNK Therapeutics Inc.2025 Trading Volume Trends & Weekly Hot Stock Watchlists - خودرو بانک
Mink Therapeutics Inc Stock (INKT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):